Exploring the Clinical Implications of Immunogenicity and Anti-drug Antibodies
Dr. Richard Moses explores immunogenicity, anti-drug antibodies, and the related factors that may affect clinical efficacy of biologics.
Date of Last Review: October 15, 2024
Document Number: VV-MED-157421
Are you satisfied with this content?